# ARMR Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/armr-systems

- Industry: Medical Devices & Equipment
- Headquarters: Boston, US
- Website: www.armrsystems.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Feb 10, 2020)
- Investors on record: 5

## About

Based in Maryland, US, ARMR Systems, Inc. focuses on developing advanced hemorrhage control products to improve trauma care, particularly in challenging pre-hospital environments.ARMR Systems, Inc. is dedicated to creating innovative medical devices that enhance trauma response. Founded in 2014 in Boston, US, by Chibueze Ihenacho and Yegor Podgorsky, the company has completed three deals, with the latest funding round occurring on September 13, 2023. ARMR Systems secured USD 250,000 in venture funding from Maryland Technology Development Corporation, bringing the total amount raised to USD 250,000.ARMR Systems, Inc. specializes in developing innovative hemorrhage control products designed to address complex trauma care challenges, particularly in pre-hospital settings where advanced medical assistance is not readily available. The company's flagship product, the XT1 Extremity Tourniquet, is engineered to provide rapid and reliable hemorrhage control, catering to both military personnel and civilians facing traumatic injuries from events such as car accidents, natural disasters, and mass casualty situations. This device is notably user-friendly, allowing for application without advanced medical training. In addition to the XT1, ARMR Systems is also working on the JT5 System, which is expected to further enhance their product offerings. The company's products are marketed primarily in the United States, with potential expansion into other international markets as their technology continues to gain recognition.ARMR Systems generates revenue through direct sales of its hemorrhage control products to various customer segments, including military organizations, first responders, and emergency medical services. Transactions are structured through direct-to-consumer sales and partnerships with medical supply distributors, enabling broad access to their innovative solutions. For instance, the XT1 Extremity Tourniquet is priced competitively to appeal to both governmental contracts and private sector buyers, emphasizing affordability and efficacy in life-saving situations. Revenue is driven by a combination of one-time purchases and potential recurring contracts with institutional clients, reflecting the critical nature of the products and the ongoing need for effective trauma care solutions in various environments.In September 2023, ARMR Systems LLC raised USD 250,000 in venture funding from returning investor Maryland Technology Development Corporation. The company will utilize this funding to create a new device and expand its market reach. Plans include launching new products, specifically the JT5 System, while also targeting expansion into additional geographic markets to enhance accessibility of their advanced trauma care solutions.

## Funding rounds

- Seed, Feb 10, 2020, $0.8M — Tamiami Angel Fund, University of Maryland, Maryland Momentum Fund
- Seed, Mar 21, 2018, $0.1M — 301 Ventures, Maryland Technology Development Corporation

## Investors

- 301 Ventures (https://capitalatlas.ai/funds/301-ventures) — Seed
- Maryland Technology Development Corporation — Seed
- Tamiami Angel Fund (https://capitalatlas.ai/funds/tamiami-angel-fund) — Seed
- University of Maryland — Seed
- Maryland Momentum Fund (https://capitalatlas.ai/funds/maryland-momentum-fund) — Seed